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Abstract
Lactococcus lactis, the model lactic acid bacterium (LAB), is a food grade and well-characterized
Gram positive bacterium. It is a good candidate for heterologous protein delivery in foodstuff or
in the digestive tract. L. lactis can also be used as a protein producer in fermentor. Many
heterologous proteins have already been produced in L. lactis but only few reports allow comparing
production yields for a given protein either produced intracellularly or secreted in the medium.
Here, we review several works evaluating the influence of the localization on the production yields
of several heterologous proteins produced in L. lactis. The questions of size limits, conformation,
and proteolysis are addressed and discussed with regard to protein yields. These data show that i)
secretion is preferable to cytoplasmic production; ii) secretion enhancement (by signal peptide and
propeptide optimization) results in increased production yield; iii) protein conformation rather
than protein size can impair secretion and thus alter production yields; and iv) fusion of a stable
protein can stabilize labile proteins. The role of intracellular proteolysis on heterologous
cytoplasmic proteins and precursors is discussed. The new challenges now are the development of
food grade systems and the identification and optimization of host factors affecting heterologous
protein production not only in L. lactis, but also in other LAB species.
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Introduction
Lactic Acid Bacteria (LAB) are anaerobic Gram positive
bacteria with a GRAS (Generally Regarded As Safe) status.
They are also food grade bacteria, and therefore, they can
be used for the delivery of proteins of interest in foodstuff
or in the digestive tract. A last advantage compared to
other well-known protein producers is that L. lactis does
not produce LPS or any proteases as Escherichia coli or
Bacillus subtilis do, respectively.
In the last two decades, genetic tools for the model LAB,
Lactococcus lactis, were developed: transformation proto-
cols, cloning- or screening-vectors [1,2], and mutagenesis
systems [3] are now available. Moreover L. lactis genome
is entirely sequenced [4]. Many protein expression- and
targeting-systems have also been designed for L. lactis [5-
7]. These systems have been used to engineer L. lactis for
the intra- or extra-cellular production of numerous pro-
teins of viral, bacterial or eukaryotic origins (Table 1). To
produce a protein of interest in fermentors, secretion is
generally preferred to cytoplasmic production because it
allows continuous culture and simplifies purification. To
use L. lactis as a protein delivery vehicle in the digestive
tract of humans or animals, secretion is also preferable
because it facilitates interaction between the protein (e.g.
enzyme or antigen) and its target (substrate or immune
system).
In LAB, like in other Gram positive bacteria, secreted pro-
teins are synthesized as a precursor containing an N-ter-
minal extension called the signal peptide (SP) and the
mature moiety of the protein. Precursors are recognized
by the host secretion machinery and translocated across
the cytoplasmic membrane (early steps). The SP is then
cleaved and degraded, and the mature protein is released
in the culture supernatant (late steps). Sometimes,
secreted proteins require subsequent folding and matura-
tion steps to acquire their active conformation [8].
In most of the works describing heterologous protein pro-
duction by recombinant lactococci, only one cellular-
location (i.e. cytoplasm, external media or surface
anchored) is described. Only a few works report the pro-
duction of a given protein in different locations using the
same backbone vector, the same induction level and or
promoter strength, allowing thus a rigorous comparison
of the production yields of cytoplasmic and secreted
forms.
Here, six examples of different heterologous proteins pro-
duced in L. lactis in both secreted and cytoplasmic forms
are reviewed and discussed. Our major conclusion is that
the best production yields are observed in most of these
cases with secretion (up to five-fold higher than with cyto-
plasmic production). Moreover, engineering the expres-
sion cassette to enhance the secretion efficiency (SE,
proportion of the total protein detected as mature form in
the supernatant) resulted in increased overall amounts of
the protein. L. lactis is able to secrete proteins ranging
from low-(< 10 kDa) to high-(> 160 kDa) molecular mass
through a Sec-dependant pathway. Altogether, these
observations suggest that i) heterologous proteins pro-
duced in L. lactis are prone to intracellular degradation
whereas secretion allows the precursor to escape proteol-
ysis, and ii) conformation rather than protein size is the
predominant feature that can impair SE. New perspectives
are now opened in the studies of heterologous protein
production in L. lactis. Indeed, there is a need for food
grade systems and for a better understanding of the host
factors influencing heterologous protein secretion in L.
lactis . For example, HtrA-mediated proteolysis (HtrA is
the unique housekeeping protease at the cell surface) is
now well-characterized in L. lactis [9] and can be over-
come by use of a htrA L. lactis strain designed for stable
heterologous protein secretion [10]. However, intracellu-
lar proteolysis (involving Clp complex -the major cyto-
plasmic housekeeping protease-, and probably other
cellular components) remains poorly understood and is
also discussed here.
Get out to get more
Genetic tools to target a given protein in different cellular
compartments were developed using several reporter pro-
teins [6,11-13] (Table 1). The staphylococcal nuclease
(Nuc) is a well-characterized secreted protein whose activ-
ity is readily detectable by petri plate assay and it has been
used as a reporter protein for secretion studies in several
Gram positive hosts [14-16]. In L. lactis, Nuc was used to
develop protein targeting- [6] and SP screening-systems
[1,2]. Nuc was chosen to develop the pCYT and pSEC vec-
tors for controlled production in L. lactis of cytoplasmic or
secreted forms of a protein of interest, respectively (Fig. 1)
[5]. The pCYT and pSEC plasmids, where expression is
controlled by a nisin inducible promoter, should be used
in L. lactis NZ9000 (hereafter referred to as NZ) strain
bearing a nisR,K chromosomal cassette, required for the
nisin signal transduction [17]. In each case described
below, protein sample concentration was adjusted to the
cell density of the producing culture (for details see [18]).
At similar induction levels in lactococcal strains contain-
ing pCYT:Nuc and pSEC:Nuc vectors, the highest produc-
tion yields were observed with the secreted Nuc form
(Table 2). Similar results were obtained with constitutive
nuc  expression cassettes for cytoplasmic and secreted
forms. Nuc was the first heterologous protein where high-
est protein yields were obtained with the secreted form.
Similar results were obtained for the production of a Bru-
cella abortus ribosomal protein. B. abortus is a facultative
intracellular Gram negative bacterial pathogen that infectsMicrobial Cell Factories 2005, 4:2 http://www.microbialcellfactories.com/content/4/1/2
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Table 1: Heterologous proteins produced in Lactococcus lactis.
Proteins Gene Origin Location References
Reporter
Nuc nuc Staphylococcus aureus Cytoplasmic / secreted 
/ anchored
[6, 16]
β-lactamase bla Escherichia coli secreted [44]
β-galactosidase β-gal Clostridium acetobutylicum cytoplasmic [45]
lactamase lacL, lacM Leuconostoc mesenteroides cytoplasmic [46]
α-amylase amyS Geobacillus (formerly Bacillus) 
stearothermophilus
secreted [47] [18]
α-amylase amyL Bacillus licheniformis secreted [48]
Chloramphenicol Acetyl Transferase cat-86 Bacillus pumilus cytoplasmic [49]
M6 Streptococcus pyogenes anchored [12]
Green fluorescent protein gfp Aequoria victoria (jellyfish) cytoplasmic [50]
luciferase luxAB Vibrio harveyi cytoplasmic [51]
luciferase Vf lux Vibrio fischeri cytoplasmic [52]
Streptavidin SA Streptomyces avidinii anchored [11]
β-glucuronidase gus Escherichia coli cytoplasmic [53]
Bacterial antigens
L7/L12 L7/L12 Brucella abortus Cytoplasmic/secreted/
anchored
[19]
Urease subunit B Helicobacter pilori secreted [54]
TTFC ttfc Clostridium tetani secreted [55]
Eukaryotic antigen
GLURP-MSP3 fusion protein Plasmodium falciparum secreted [56]
Viral antigens
E7 E7 HPV type-16 cytoplasmic/secreted/
anchored
[20] [57]
NSP4 NSP4 Bovine coronavirus cytoplasmic [29]
BCV epitope BCV Bovine coronavirus secreted [58]
VP8 subunit of VP4 VP8* rotavirus secreted [59]
Interleukins
IL-2 IL-2 Mouse secreted [60]
IL-6 IL-6 Mouse secreted [61]
IL-10 IL-10 Mouse secreted [21]
IL-12 IL-12 Mouse Secreted [22]
IFN-ω IFN-ω Ovine secreted [5]
Allergens
BLG Blg Bovine cytoplasmic/secreted [13, 30, 36]
Epitope Blg41–60 Bovine secreted
Virulence factors
Fibronectin binding protein A fnbpA Staphylococcus aureus anchored [62]
Clumping factor A clfA Staphylococcus aureus anchored [63]
Clumping factor A and B clfB Staphylococcus aureus anchored [64]
serine-aspartate repeat protein sdrE Staphylococcus aureus anchored [64]
Protein A spA Staphylococcus aureus anchored [11]
Enterotoxin A sea Staphylococcus aureus secreted C. Charlier(a)
Unpublished results
Aggregation substance asc10 Enterococcus faecalis anchored [65]
Capsular polysaccharides cps genes Streptococcus pneumoniae CPS excreted [66]
Internalin inlA Listeria monocytogenes anchored V. Guimarães(b)
Unpublished results
BacteriocinsMicrobial Cell Factories 2005, 4:2 http://www.microbialcellfactories.com/content/4/1/2
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human and animals by entry through the digestive tract.
The immunogenic B. abortus ribosomal protein L7/L12 is
a promising candidate for the development of oral live
vaccines against brucellosis using L. lactis as a delivery vec-
tor. L7/L12 was produced in L. lactis using pCYT and pSEC
vectors [19]. Similarly to Nuc production, the production
yield of secreted L7/L12 was reproducibly and signifi-
cantly higher than that of the cytoplasmic form (Table 2).
Another example of higher protein yields in secreted vs
cytoplasmic form is the production the human papillo-
mavirus type 16 (HPV-16) E7 antigen, a good candidate
for the development of therapeutic vaccines against HPV-
16 induced cervical cancer. The E7 protein is constitu-
tively produced in cervical carcinomas and interacts with
several cell compounds. E7 was produced in a cytoplasmic
and a secreted form in L. lactis [20]. Using similar induc-
tion level in exponential phase cultures, E7 production
ABP-118 abp118 Lactobacillus salivarius subsp. 
salivarius
secreted [67]
Enterocin A ent genes Enterococcus faecium secreted [68]
Pediocin PA-1 ped genes Pediococcus acidilactici secreted [68]
colicin V Escherichia coli secreted [69]
Enzymes
heat-stable alpha-glucosidase malA Sulfolobus solfataricus cytoplasmic [70]
Bacteriophage lytic enzyme ply 118 Listeria monocytogenes 
bacteriophage
secreted [71]
lysozyme hel Hen egg white cytoplasmic [72]
Neutral protease npr Bacillus subtilis secreted [73]
Aminopeptidase N pepN Lactobacillus helveticus secreted [74]
Cell Surface Protease prtB Lactobacillus delbrueckii subsp. 
bulgaricus
anchored [13]
Dextrane sucrase dsrD Leuconostoc mesenteroides secreted [28]
Streptodornase sdc Streptococcus equisimilis secreted [75]
prochymosin PC Bovine secreted [76]
lipase lip Staphylococcus hyicus secreted [77]
plasmin Bovine secreted [78]
others
F18 fimbrial adhesin (receptor 
binding domain)
fedF Escherichia coli Secreted / anchored [27]
S-layer protein slpH Lactobacillus helveticus cell wall associated [79]
(a) : Laboratoire de Microbiologie UMR1253 INRA Agrocampus, 65 rue de Saint Brieuc CS84215, 35042 Rennes cedex
(b) : Unité de Recherches Laitières et de Génétique Appliquée, Institut National de la Recherche Agronomique, Domaine de Vilvert, 78352 Jouy en 
Josas Cedex, France
Table 2: Comparison of the protein yields in secreted vs cytoplasmic production.
Protein Quantification of the 
secreted form1
Quantification of the 
cytoplasmic form1
Ratio sec/cyto References
Nuc 20 mg/L 3 mg/L 6 [5]
L7/L12 3 mg/L 0.5 mg/L 6 [19]
E7 (expo)* nd nd 2 to 3 [20]
E7 (stat)* nd nd > 10 [20]
IFN-ω 309 mg/L 159 mg/L 2 [5]
1: protein samples were adjusted to the cell density and protein quantification was performed as described in the references either by western blot 
or by ELISA.
*: E7 was not quantified but ratio was calculated by scanning the western blot signals and comparing their intensity as described in the 
corresponding reference.
nd: not determined
Table 1: Heterologous proteins produced in Lactococcus lactis. (Continued)Microbial Cell Factories 2005, 4:2 http://www.microbialcellfactories.com/content/4/1/2
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was higher for the secreted form than for the cytoplasmic
form (Table 2). This difference was even higher when
induction occurred in late-exponential phase, where intra-
cellular E7 was detected at only trace amount whereas
secreted E7 was accumulated in NZ(pSEC:E7) culture
supernatant (see below). Thus, production of E7 clearly
illustrates the fact that secretion results in higher yields in
L. lactis.
Production of ovine interferon omega (IFN-ω) further
illustrates this observation. In the case of poorly immuno-
genic antigens, co-delivery of an immuno-stimulator pro-
tein can enhance the immune response of the host. In
order to optimize the use of lactococci as live vaccines, the
production of cytokines was investigated in L. lactis
[5,21,22]. IFN-ω is a cytokine able to confer resistance to
enteric viruses in the digestive tract by reduction of viral
penetration and by inhibition of intracellular multiplica-
tion of the viruses. Delivery of ovine IFN-ω in the digestive
tract by recombinant L. lactis strains could therefore
induce anti-viral resistance and could protect the
enterocytes. Ovine IFN-ω cDNA was cloned into pCYT
and pSEC plasmids for intracellular (pCYT:IFN) and
secreted (pSEC:IFN) production respectively [5]. Induc-
tion of recombinant NZ(pCYT:IFN) and NZ(pSEC:IFN)
strains were performed at equal level and IFN-ω produc-
tion was measured. The levels of IFN-ω activity showed
that i) an active form of IFN-ω was produced in both
strains, and ii) the activity of IFN-ω found in the superna-
tant and cell fractions of NZ(pSEC:IFN) strain was about
two-fold higher than that observed for the cytoplasmic
form (Table 2). Similarly to what was observed for Nuc
and E7, secretion leads to higher heterologous protein
yields.
Better secretion for better yields
L. lactis has been engineered to secrete of a wide variety of
heterologous proteins from bacterial, viral or eukaryotic
origins (Table 1). There are reports about secretion bottle-
necks and biotechnological tools for heterologous secre-
tion in model bacteria such as Escherichia coli and Bacillus
subtilis [23,24], but only few data are available concerning
this aspect in L. lactis. Protein size, nature of the SP and
presence of a propeptide are parameters that may interfere
with protein secretion. Some data available about these
features are compiled here.
To optimize secretion and thus production yields, the
nature of the SP was the first parameter to modify on het-
erologous precursor as previously shown using Nuc as a
reporter protein. The replacement of the native staphylo-
coccal SPNuc by the homologous lactococcal SPUsp45 to
direct the secretion of Nuc in L. lactis led to an increased
SE [25] (Table 3). On the other hand, the replacement of
SPNuc by SPUsp45 did not enhance the SE of NucT (a trun-
cated mature moiety of Nuc devoid of N-terminal propep-
tide) suggesting the importance of the propeptide in the
SE for Nuc [25] (Table 3). However, in several cases, the
use of a homologous SP (and especially SPUsp45) allows a
better SE compared to a heterologous one. Screening vec-
tors were thus developed to search for new homologous
secretion signals in L. lactis [1,2]. These screening works
offer now a panel of SPs that are suitable for heterologous
secretion. However, when compared to SPUsp45, the newly
described SPs were less efficient to direct secretion of Nuc
[1]. Even after a direct mutagenesis on SP310, one of these
new SPs identified using a screening strategy [1], the
enhanced SE was still lower than the one measured with
SPUsp45 [26]. However, a recent study by Lindholm et al.
showed that a Lactobacillus brevis SP (originated from a S-
layer protein) drove the secretion of the E. coli FedF
Schematic representation of Nuc cassettes for controlled  and targeted production in L. lactis Figure 1
Schematic representation of Nuc cassettes for con-
trolled and targeted production in L. lactis. For details 
about plasmid constructions and contents see Bermúdez-
Humarán et al. (2003) [5]. Plasmid backbone is a derivative of 
the rolling circle plasmid pWVO1, an E. coli-Gram positive 
shuttle vector. Arrows (1) indicate the presence of the nisin-
inducible promoter (PnisA); solid vertical bars (2) indicate the 
Ribosome Binding Site of the usp45 gene; the striped bar 
indicate signal peptide of the usp45 gene (SPUsp); the white 
bar indicates the insertion of LEISSTCDA synthetic propep-
tide [18]; dark gray bars indicates Nuc mature coding 
sequence; stem-loop structures indicate trpA transcription 
terminators (not to scale). A NsiI restriction site comprises 
the ATG start codon (in pCYT) or the last two residues of 
SPUsp (pSEC) and allows a simple and one-step cloning of the 
cassettes corresponding to the mature proteins for cytoplas-
mic production (pCYT) or secretion (pSEC).
nuc
1
SPUsp nuc
nuc
pCYT:Nuc
pSEC:Nuc
pSEC:LEISS:Nuc
Plasmid names
2
NsiI
NsiI
NsiI
LEISSTCDA
MCS
MCS
MCS
SPUspMicrobial Cell Factories 2005, 4:2 http://www.microbialcellfactories.com/content/4/1/2
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adhesin more efficiently than SPUsp45 [27]. High SE might
thus result, at least in part, from good adequacy between
the mature protein and the SP used to direct secretion.
The fusion of a short synthetic propeptide between the SP
and the mature moiety is another innovative biotechno-
logical tool to enhance protein secretion. One such
propeptide (composed of nine amino acid residues,
LEISSTCDA) was developed and was shown to enhance
the SE of several heterologous proteins in L. lactis: NucB,
NucT, (Table 3) [18], the B. abortus L7/L12 antigen (Table
3) [19], and the α-amylase of Geobacillus stearother-
mophilus  (Table 3) [18]. Directed mutagenesis experi-
ments demonstrated that the positive effect of LEISSTCDA
on protein secretion was due to the insertion of negatively
charged residues in the N-terminus of the mature moiety
[25]. Furthermore, the enhancement effect does not
depend on the nature of the SP, since the secretion of
NucB fused to either SPNuc or SPUsp45 was enhanced by
LEISSTCDA insertion [25]. Strikingly, the enhancement of
SE was reproducibly accompanied by an overall increase
of protein yields as determined in Western blot experi-
ments. This observation suggests that heterologous pre-
cursors are degraded by intracellular proteases when they
are not efficiently secreted and that a higher secretion
could be a way to escape proteolysis.
Protein conformation rather than protein size 
can impair the heterologous protein secretion in 
L. lactis
Proteins with molecular mass ranging from 165 kDa (size
of DsrD, the Leuconostoc mesenteroides dextransucrase,
[28]) to 9.8 kDa (size of Afp1, a Streptomyces tendae anti-
fungal protein; Freitas et al., submitted) have been suc-
cessfully secreted in L. lactis. This suggests that protein size
is not a serious bottleneck for heterologous protein secre-
tion in L. lactis. In contrast to protein size, conformation
may be a major problem for heterologous secretion in L.
lactis  as illustrated by some recent examples. The first
example is the production of the non-structural protein 4
(NSP4) of the bovine rotavirus, the major etiologic agent
of severe diarrhea in young cattle. In order to develop live
vaccines against this virus, the NSP4 antigen was success-
fully produced in L. lactis [29]. Derivatives of pCYT and
pSEC plasmids were constructed to target NSP4 into cyto-
plasmic or extracellular location. The highest level of pro-
duction was obtained with the secreted form. However,
no secreted NSP4 was detected in the supernatant and
both SPUsp45-NSP4 precursor and NSP4 mature protein
were detected in the cell fraction. Two degradation prod-
ucts were detected in addition to the NSP4 precursor and
mature protein. These results suggest that the cytoplasmic
form of NSP4 was probably totally degraded inside the
cell whereas fusion to the SPUsp45 protected NSP4 protein
against intracellular proteolysis.
Similar results were obtained when pCYT and pSEC vec-
tors were used to produce the B. abortus GroEL chaperone
protein: only pSEC:GroEL plasmid was obtained and sub-
sequently the fusion SPUsp45:GroEL was detected in West-
ern blot experiments (V. Azevedo, unpublished data). In
this case, B. abortus GroEL is likely to interact with lacto-
coccal cytoplasmic proteins leading to severe cellular
defects and thus to a lethal phenotype. On the other hand,
fusion of SPUsp to GroEL might keep the chimeric protein
in an unfolded and/or inactive state allowing thus its het-
erologous production.
Another example is the production of the bovine β-lac-
toglobulin (BLG) in L. lactis [30,31]. BLG, a 162 amino
acid residues globular protein, is the dominant allergen in
cow's milk and was produced in L. lactis to test the immu-
nomodulation of the allergenic response in mice when
BLG is delivered by a bacterial vector [30]. Western blot
and ELISA showed that BLG production was significantly
higher when BLG was fused to SPUsp45 although the SE was
Table 3: Effect of the signal peptide and of the insertion of the LEISSTCDA synthetic propeptide on the secretion efficiency.
Protein SEa with SPNuc SE with SPUsp45 Reference
Nuc 60 % >95 % [25]
NucT 30 % 30 % [25]
Protein SE without LEISS SE with LEISS Reference
N u c 6 0  %8 0  %[ 1 8 ]
NucT 30 % 90 % [25]
L7/L12 35 % 50 % [19]
AmySb + +++ [18]
a: SE, secretion efficiency is the proportion of total protein which is present in the mature secreted form.
b: SE was not determined by western blot and immuno revelation and thus could not be quantified but the activity plate assay demonstrated a clear 
secretion enhancement (+ to +++) with LEISS.Microbial Cell Factories 2005, 4:2 http://www.microbialcellfactories.com/content/4/1/2
Page 7 of 13
(page number not for citation purposes)
very low, with no detectable BLG in the supernatant of
pSEC:BLG strains [30]. Further studies revealed that a
fusion between the LEISS propeptide and BLG could not
enhance the SE of BLG above ~5%, as determined by
ELISA [31].
For rotavirus NSP4, B. abortus GroEL, and BLG (which are
medium-sized compared to DsrD or Afp1), either very
low secretion yields or absence of secretion was observed
in L. lactis. In all cases, fusion to a SP stabilizes heterolo-
gous protein production even though they are not effi-
ciently secreted. These results could be due either to the SP
itself that reportedly acts as an intramolecular chaperone
or to the protection of the chimeric precursor from intra-
cellular proteolysis by the cytoplasmic chaperones of the
Sec-machinery. GroEL (a cytoplasmic chaperone), NSP4
(a structural protein), and BLG (a globular protein) have
dramatically different primary sequences. A higher affinity
of intracellular housekeeping proteases for these particu-
lar sequences cannot be hypothesized since the fusion of
a SP leads to the stabilization of the protein. Change of
conformation is therefore the predominant criterion
involved in the stabilization of the precursors and the
higher yields observed. On the other hand, these proteins
might undergo rapid folding right after their synthesis,
which interferes with (or hampers) the secretion process.
Such interferences between protein conformation and SE
were previously shown in E. coli and B. subtilis [32,33].
Altogether, these results suggest that protein conforma-
tion rather than protein size is a major problem for heter-
ologous protein secretion in L. lactis as well.
A labile protein can be stabilized by fusion to a 
stable protein
It was clearly demonstrated that the secreted form of E7, a
reportedly labile protein, can be stabilized by fusion to
Nuc [20,34]. Nuc is reportedly a stable protein and its use,
as a fusion partner, does not affect its enzymatic activity.
The production of the resulting chimerical protein is thus
easy to follow. The cytoplasmic form of E7 was stabilized
by the fusion to Nuc even when the production was
induced in stationary phase (Fig. 2A), whereas cytoplas-
mic E7 alone was degraded (see below; Fig. 3). Thus,
fusion to the stable Nuc could rescue E7 production in L.
lactis and allowed higher protein yields compared to E7
alone [20]. Stabilization by fusion to Nuc was observed
for several secreted proteins as well. First, a Nuc-E7 fusion
on a pSEC backbone resulted in higher production yield
although the SE was altered (Fig. 2B). Fusion to the syn-
thetic propeptide LEISSTCDA in a pSEC:LEISS:Nuc:E7
construction restored an efficient secretion yield [34]. Sec-
ond, in an attempt to increase the protein yield of the
secreted L7/L12, a fusion to Nuc (pSEC:Nuc:L7/L12)
resulted in a 2.5-fold increase in production yield (Fig.
2B) [19]. Recent results concerning the production of BLG
provide a third example of yield enhancement by fusion
to Nuc. A pSEC:Nuc:BLG construction allowed a 2-fold
increase in BLG yields compared to pSEC:BLG [31]. These
results show that Nuc is a stable carrier protein and has a
protective effect on labile heterologous chimerical pro-
teins by reducing its sensitivity to intracellular proteolysis.
To our knowledge, Nuc is the fusion partner most com-
monly tested so far for stabilization in L. lactis. Bernasconi
et al (2002) fused the Lactobacillus bulgaricus proteinase
PrtB to BLG, which was subsequently stabilized by the
PrtB carrier [13]. It is thus difficult to postulate any rule
concerning the stabilization effect. Different results (i.e.
no stabilization) could perhaps be observed with a differ-
ent partner and thus could help to determine the mecha-
nism of the stabilization effect. In biotechnological use of
recombinant  L. lactis strains for protein production,
fusions can also facilitate purification (e.g. His-tag strat-
egy). Protein fusion has also been successfully used to
optimize the production of the two subunits of het-
erodimeric complexes as demonstrated with murine inter-
leukin-12 in L. lactis [22] or with heterodimeric enzymes
in E. coli [35]. In both cases, the resulting fusion had the
expected properties. In other cases however, such fusions
might dramatically interfere with the conformation of one
or both of the proteins, which might be deleterious for the
expected activity. Nevertheless, when L. lactis is used as an
antigen delivery vector, fusions can be envisioned since it
was demonstrated that both moieties of the chimerical
protein are still recognized by the corresponding antise-
rum [10,20,34] and are immunogenic [36].
Secretion avoids proteolysis?
Several of the results mentioned above suggest that secre-
tion could be an efficient way to escape intracellular pro-
teolysis. This hypothesis was particularly tested in E7
production [20]. E7 was indeed degraded when intracellu-
lar production was induced in late exponential or early
stationary growth phase (Fig. 3). E7 production was then
tested in a clpP deficient strain (ClpP is reportedly the
major house keeping protease in L. lactis; [37]) and in a
dnaK deficient strain (DnaK is an intracellular chaperone
that may promote proteolysis by maintaining the protein
in an unfolded state; [38]). In exponential or stationary
phase cultures, no significant difference in E7 patterns was
observed between wild type and clpP- (Fig. 3) or dnaK- (not
shown) strains: E7 was equally degraded in the cytoplasm
and remained unchanged in supernatants samples. Alto-
gether, these results indicate that E7 intracellular proteol-
ysis is ClpP- and DnaK- independent. Until recently, only
two cytoplasmic proteases, ClpP and FtsH [39], have been
identified in L. lactis. The existence of a third, as yet uni-
dentified protease was postulated by studies of a clpP
mutant suppressor [40]. E7 may thus be a useful screening
target to identify a putative L. lactis protease that, as sug-
gested by our data, is activated in stationary phase.Microbial Cell Factories 2005, 4:2 http://www.microbialcellfactories.com/content/4/1/2
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Besides the features of the precursor itself, these results
also rise that host factors are involved in protein stability
and SE (Fig. 4). Research efforts are now focusing on the
analysis of host factors involved in protein production
and secretion by either directed or random mutagenesis in
L. lactis [41].
Although  L. lactis possesses a wide range of enzymes
(peptidases, housekeeping proteases) dedicated to intrac-
ellular proteolysis, it possesses only one extracellular
housekeeping protease (HtrA) [9] and its major extracel-
lular scavenger protease, PrtP, is plasmid encoded [42].
Thus, a plasmidless strain does not present any protease
activity in the medium. Better production yields could
then be expected when secretion is used versus cytoplas-
mic production. These results give clues and provide the
research workers with target proteins to study intracellular
proteolysis and protein stability inside and outside the
host strain. Such studies already led to the development of
htrA deficient L. lactis strains. Heterologous protein secre-
tion and anchoring in a htrA  deficient strain allowed
Fusion to Nuc rescue E7 in intracellular production and increase protein yields for the secreted forms of E7 and L7/L12 Figure 2
Fusion to Nuc rescue E7 in intracellular production and increase protein yields for the secreted forms of E7 
and L7/L12. A. A DNA fragment encoding the mature moiety of Nuc was fused to the fragment encoding E7 (pCYT:Nuc:E7). 
Production of Nuc-E7 analyzed by Western blot using anti-E7 antibodies on protein samples prepared from induced cultures 
harvested either at exponential (exp) or stationary (stat) phase. Positions and sizes of molecular weight marker (M) are indi-
cated at left. B. The mature Nuc fragment was inserted between SPUsp45 and the fragment encoding E7 (pSEC:Nuc:E7) or L7/
L12 (pSEC:Nuc:L7/L12). Secretion of the fusion proteins was analyzed by Western blot using either anti-E7 or anti-L7/L12 anti-
bodies. C, cell lysates; S, supernatant fraction. Positions of precursor (prec) or mature forms of E7, Nuc-E7, L7/L12, NucB-L7/
L12, and NucA-L7/L12 are indicated by arrows.
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Native E7 production in wt L. lactis depends on growth phase Figure 3
Native E7 production in wt L. lactis depends on growth phase. E7 production and secretion were analyzed by Western 
blot from cultures induced at different times so that, 1 hour after nisin induction, the samples are harvested at exponential 
(OD600 = 0.5–0.6, upper panels) or stationary phase (OD600 = 1.5, lower panels). wt/pCYT-E7, NZ(pCYT-E7) strain (encoding 
native E7, cytoplasmic form). wt/pSEC-E7 NZ(pSEC-E7) strain (encoding the precursor preE7). Positions of E7 mature and pre-
cursor forms are given by arrows. C, cell lysates; S, supernatant fraction. ClpP is not involved in the intracellular degra-
dation of E7 in L. lactis. Analysis by western blot shows that a strain of L. lactis deficient in the intracellular protease ClpP 
cannot rescue cytoplasmic E7 production. Induced cultures samples of wt L. lactis or L. lactis clpP mutant strain containing 
pCYT-E7 (clpP/pCYT-E7) or pSEC-E7 (clpP/pSEC-E7) taken at exponential- (upper panel) or stationary- (lower panel) phase.
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higher protein stability at the cell surface for several heter-
ologous proteins [10].
Perspectives
Current research works are now focusing on other host
factors that affect protein production and secretion in L.
lactis.  L. lactis complete genome sequence analysis
revealed indeed that the Sec machinery comprises fewer
components than the well-characterized B. subtilis Sec
machinery. Notably, L. lactis does not possess any SecDF
equivalent and complementation of the lactococcal Sec
machinery with B. subtilis SecDF results in better secretion
yields as determined for Nuc reporter protein (Nouaille et
al., submitted). Random mutagenesis approaches also
revealed that features of some cell compartment, such as
the cell wall, play an important role in the secretion proc-
ess [41]. Similar approaches allowed the identification
and characterization of genes of unknown functions spe-
cifically involved in production yields of the secreted pro-
teins in L. lactis (Nouaille et al., in preparation).
Many molecular tools are now available to direct heterol-
ogous protein secretion in L. lactis and the list of heterol-
ogous proteins produced in this bacterium is regularly
increased. The reports where cytoplasmic and secretion
production can be compared mostly show that secretion
allows better protein yields compared to intracellular
Schematic presentation of the molecular tools and the cellular events that can affect the production yields of heterologous pro- tein in L. lactis Figure 4
Schematic presentation of the molecular tools and the cellular events that can affect the production yields of 
heterologous protein in L. lactis. Thicknesses of the arrows are proportional to the final production yields. All the host fac-
tors involved in the cellular events are not identified and or characterized yet. SP, signal peptide (encoded in pSEC construc-
tions), +Nuc, fusion between the protein of interest and the stable Nuc protein.
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production; and allow a better understanding of the pro-
tein production and secretion process in L. lactis.
Future works should investigate the L. lactis capacities for
protein modifications. For example, we showed that
proteins that require a disulfide bond (DSB) to acquire
their native conformation can be efficiently produced and
secreted in L. lactis [5,22,27]. However, no equivalent of
E. coli dsb or B. subtilis bdb, the genes involved in DSB
formation, was found by sequence comparison in L. lactis.
Similarly, other folding elements (i.e. PPIases, so-called
maturases...) are still to be identified and the L. lactis
capacities for post-translational modifications are still to
be investigated.
Altogether, these works will contribute to the develop-
ment and the improvement of new food-grade systems for
L. lactis [43] and should lead, in a near future, to the con-
struction of lactococcal strains dedicated to high-level
production of proteins of interest. The GRAS status of L.
lactis and LAB in general, is a clear advantage for their use
in production and secretion of therapeutic or vaccinal
proteins.
Acknowledgements
Anderson MIYOSHI, Daniela FREITAS, Luciana RIBEIRO, Jane E. GABRIEL, 
Sophie LECLERCQ, Maricê N. OLIVEIRA, and Valeria D. GUIMARÃES 
were recipients of a CAPES fellowship (project CAPES-COFECUB #319-
II). Luis BERMUDEZ and Sébastien NOUAILLE were recipients of a fellow-
ship from the French Ministry of Education and Research. INRA and Région 
Ile-de-France also financed L. BERMUDEZ and V. GUIMARAES. Cathy 
CHARLIER is recipient of a fellowship from INRA and Région Bretagne.
References
1. Ravn P, Arnau J, Madsen SM, Vrang A, Israelsen H: The develop-
ment of TnNuc and its use for the isolation of novel secretion
signals in Lactococcus lactis. Gene 2000, 242:347-356.
2. Poquet I, Ehrlich SD, Gruss A: An export-specific reporter
designed for gram-positive bacteria: application to Lacto-
coccus lactis. J Bacteriol 1998, 180:1904-1912.
3. Maguin E, Prevost H, Ehrlich SD, Gruss A: Efficient insertional
mutagenesis in lactococci and other gram-positive bacteria.
J Bacteriol 1996, 178:931-935.
4. Bolotin A, Wincker P, Mauger S, Jaillon O, Malarme K, Weissenbach
J, Ehrlich SD, Sorokin A: The complete genome sequence of the
lactic acid bacterium Lactococcus lactis ssp. lactis IL1403.
Genome Res 2001, 11:731-753.
5. Bermudez-Humaran LG, Langella P, Commissaire J, Gilbert S, Le Loir
Y, L'Haridon R, Corthier G: Controlled intra- or extracellular
production of staphylococcal nuclease and ovine omega
interferon in Lactococcus lactis.  FEMS Microbiol Lett 2003,
224:307-313.
6. Dieye Y, Usai S, Clier F, Gruss A, Piard JC: Design of a protein-tar-
geting system for lactic acid bacteria.  J Bacteriol 2001,
183:4157-4166.
7. de Vos WM: Gene expression systems for lactic acid bacteria.
Curr Opin Microbiol 1999, 2:289-295.
8. Pugsley AP, Possot O: The general secretory pathway of Kleb-
siella oxytoca: no evidence for relocalization or assembly of
pilin-like PulG protein into a multiprotein complex.  Mol
Microbiol 1993, 10:665-674.
9. Poquet I, Saint V, Seznec E, Simoes N, Bolotin A, Gruss A: HtrA is
the unique surface housekeeping protease in Lactococcus
lactis and is required for natural protein processing.  Mol
Microbiol 2000, 35:1042-1051.
10. Miyoshi A, Poquet I, Azevedo V, Commissaire J, Bermudez-Humaran
L, Domakova E, Le Loir Y, Oliveira SC, Gruss A, Langella P: Control-
led production of stable heterologous proteins in Lactococ-
cus lactis. Appl Environ Microbiol 2002, 68:3141-3146.
11. Steidler L, Viaene J, Fiers W, Remaut E: Functional display of a
heterologous protein on the surface of Lactococcus lactis by
means of the cell wall anchor of Staphylococcus aureus pro-
tein A. Appl Environ Microbiol 1998, 64:342-345.
12. Piard JC, Hautefort I, Fischetti VA, Ehrlich SD, Fons M, Gruss A: Cell
wall anchoring of the Streptococcus pyogenes M6 protein in
various lactic acid bacteria. J Bacteriol 1997, 179:3068-3072.
13. Bernasconi E, Germond JE, Delley M, Fritsche R, Corthesy B: Lacto-
bacillus bulgaricus proteinase expressed in Lactococcus lac-
tis is a powerful carrier for cell wall-associated and secreted
bovine beta-lactoglobulin fusion proteins. Appl Environ Microbiol
2002, 68:2917-2923.
14. Miller JR, Kovacevic S, Veal LE: Secretion and processing of sta-
phylococcal nuclease by Bacillus subtilis.  J Bacteriol 1987,
169:3508-3514.
15. Liebl W, Sinskey AJ, Schleifer KH: Expression, secretion, and
processing of staphylococcal nuclease by Corynebacterium
glutamicum. J Bacteriol 1992, 174:1854-1861.
16. Le Loir Y, Gruss A, Ehrlich SD, Langella P: Direct screening of
recombinants in gram-positive bacteria using the secreted
staphylococcal nuclease as a reporter.  J Bacteriol 1994,
176:5135-5139.
17. Kuipers OP, de Ruyter PG, Kleerebezem M, de Vos WM: Control-
led overproduction of proteins by lactic acid bacteria. Trends
Biotechnol 1997, 15:135-140.
18. Le Loir Y, Gruss A, Ehrlich SD, Langella P: A nine-residue syn-
thetic propeptide enhances secretion efficiency of heterolo-
gous proteins in Lactococcus lactis.  J Bacteriol 1998,
180:1895-1903.
19. Ribeiro LA, Azevedo V, Le Loir Y, Oliveira SC, Dieye Y, Piard JC,
Gruss A, Langella P: Production and targeting of the Brucella
abortus antigen L7/L12 in Lactococcus lactis: a first step
towards food-grade live vaccines against brucellosis. Appl Envi-
ron Microbiol 2002, 68:910-916.
20. Bermudez-Humaran LG, Langella P, Miyoshi A, Gruss A, Guerra RT,
Montes de Oca-Luna R, Le Loir Y: Production of human papillo-
mavirus type 16 E7 protein in Lactococcus lactis. Appl Environ
Microbiol 2002, 68:917-922.
21. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers
W, Remaut E: Treatment of murine colitis by Lactococcus lac-
tis secreting interleukin-10. Science 2000, 289:1352-1355.
22. Bermudez-Humaran LG, Langella P, Cortes-Perez NG, Gruss A,
Tamez-Guerra RS, Oliveira SC, Saucedo-Cardenas O, Montes de
Oca-Luna R, Le Loir Y: Intranasal immunization with recom-
binant Lactococcus lactis secreting murine interleukin-12
enhances antigen-specific Th1 cytokine production.  Infect
Immun 2003, 71:1887-1896.
23. Shokri A, Sanden AM, Larsson G: Cell and process design for tar-
geting of recombinant protein into the culture medium of
Escherichia coli. Appl Microbiol Biotechnol 2003, 60:654-664.
24. Braun P, Gerritse G, van Dijl JM, Quax WJ: Improving protein
secretion by engineering components of the bacterial trans-
location machinery. Curr Opin Biotechnol 1999, 10:376-381.
25. Le Loir Y, Nouaille S, Commissaire J, Bretigny L, Gruss A, Langella P:
Signal peptide and propeptide optimization for heterolo-
gous protein secretion in Lactococcus lactis.  Appl Environ
Microbiol 2001, 67:4119-4127.
26. Ravn P, Arnau J, Madsen SM, Vrang A, Israelsen H: Optimization of
signal peptide SP310 for heterologous protein production in
Lactococcus lactis. Microbiology 2003, 149:2193-2201.
27. Lindholm A, Smeds A, Palva A: Receptor binding domain of
Escherichia coli F18 fimbrial adhesin FedF can be both effi-
ciently secreted and surface displayed in a functional form in
Lactococcus lactis. Appl Environ Microbiol 2004, 70:2061-2071.
28. Neubauer H, Bauche A, Mollet B: Molecular characterization and
expression analysis of the dextransucrase DsrD of Leuconos-
toc mesenteroides Lcc4 in homologous and heterologous
Lactococcus lactis cultures. Microbiology 2003, 149:973-982.
29. Enouf V, Langella P, Commissaire J, Cohen J, Corthier G: Bovine
rotavirus nonstructural protein 4 produced by Lactococcus
lactis is antigenic and immunogenic. Appl Environ Microbiol 2001,
67:1423-1428.Microbial Cell Factories 2005, 4:2 http://www.microbialcellfactories.com/content/4/1/2
Page 12 of 13
(page number not for citation purposes)
30. Chatel JM, Langella P, Adel-Patient K, Commissaire J, Wal JM, Cor-
thier G: Induction of mucosal immune response after intrana-
sal or oral inoculation of mice with Lactococcus lactis
producing bovine beta-lactoglobulin.  Clin Diagn Lab Immunol
2001, 8:545-551.
31. Nouaille S, Bermudez-Humaran L, Adel-Patient K, Commissaire J,
Wal JM, Azevedo V, Langella P, Chatel JM: Improvement of bovine
beta-lactoglobulin production and secretion in Lactococcus
lactis. Braz J Med Biol Res  in press.
32. Petit-Glatron MF, Monteil I, Benyahia F, Chambert R: Bacillus subti-
lis levansucrase: amino acid substitutions at one site affect
secretion efficiency and refolding kinetics mediated by
metals. Mol Microbiol 1990, 4:2063-2070.
33. Haddaoui EA, Leloup L, Petit-Glatron MF, Chambert R: Character-
ization of a stable intermediate trapped during reversible
refolding of Bacillus subtilis alpha-amylase. Eur J Biochem 1997,
249:505-509.
34. Bermudez-Humaran LG, Cortes-Perez NG, Le Loir Y, Gruss A, Rod-
riguez-Padilla C, Saucedo-Cardenas O, Langella P, Montes de Oca-
Luna R: Fusion to a carrier protein and a synthetic propeptide
enhances E7 HPV-16 production and secretion in Lactococ-
cus lactis. Biotechnol Prog 2003, 19:1101-1104.
35. Burke C, Klettke K, Croteau R: Heteromeric geranyl diphos-
phate synthase from mint: construction of a functional fusion
protein and inhibition by bisphosphonate substrate analogs.
Arch Biochem Biophys 2004, 422:52-60.
36. Chatel JM, Nouaille S, Adel-Patient K, Le Loir Y, Boe H, Gruss A, Wal
JM, Langella P: Characterization of a Lactococcus lactis strain
that secretes a major epitope of bovine beta-lactoglobulin
and evaluation of its immunogenicity in mice.  Appl Environ
Microbiol 2003, 69:6620-6627.
37. Frees D, Ingmer H: ClpP participates in the degradation of mis-
folded protein in Lactococcus lactis.  Mol Microbiol 1999,
31:79-87.
38. Koch B, Kilstrup M, Vogensen FK, Hammer K: Induced levels of
heat shock proteins in a dnaK mutant of Lactococcus lactis.
J Bacteriol 1998, 180:3873-3881.
39. Nilsson D, Lauridsen AA, Tomoyasu T, Ogura T: A Lactococcus
lactis gene encodes a membrane protein with putative
ATPase activity that is homologous to the essential
Escherichia coli ftsH gene product. Microbiology 1994, 140 (Pt
10):2601-2610.
40. Frees D, Varmanen P, Ingmer H: Inactivation of a gene that is
highly conserved in Gram-positive bacteria stimulates deg-
radation of non-native proteins and concomitantly increases
stress tolerance in Lactococcus lactis.  Mol Microbiol 2001,
41:93-103.
41. Nouaille S, Commissaire J, Gratadoux JJ, Ravn P, Bolotin A, Gruss A,
Le Loir Y, Langella P: Influence of lipoteichoic acid D-alanyla-
tion on protein secretion in Lactococcus lactis as revealed by
random mutagenesis. Appl Environ Microbiol 2004, 70:1600-1607.
42. de Vos WM, Vos P, de Haard H, Boerrigter I: Cloning and expres-
sion of the Lactococcus lactis subsp. cremoris SK11 gene
encoding an extracellular serine proteinase.  Gene 1989,
85:169-176.
43. Johansen E: Challenges when transferring technology from
Lactococcus laboratory strains to industrial strains. Genet Mol
Res 2003, 2:112-116.
44. Sibakov M, Koivula T, von Wright A, Palva I: Secretion of TEM
beta-lactamase with signal sequences isolated from the
chromosome of Lactococcus lactis subsp. lactis. Appl Environ
Microbiol 1991, 57:341-348.
45. Pillidge CJ, Pearce LE: Expression of a beta-galactosidase gene
from Clostridium acetobutylicum in Lactococcus lactis
subsp. lactis. J Appl Bacteriol 1991, 71:78-85.
46. Israelsen H, Madsen SM, Vrang A, Hansen EB, Johansen E: Cloning
and partial characterization of regulated promoters from
Lactococcus lactis Tn917-lacZ integrants with the new pro-
moter probe vector, pAK80.  Appl Environ Microbiol 1995,
61:2540-2547.
47. van Asseldonk M, de Vos WM, Simons G: Functional analysis of
the Lactococcus lactis usp45 secretion signal in the secretion
of a homologous proteinase and a heterologous alpha-amy-
lase. Mol Gen Genet 1993, 240:428-434.
48. Perez-Martinez G, Kok J, Venema G, van Dijl JM, Smith H, Bron S:
Protein export elements from Lactococcus lactis. Mol Gen
Genet 1992, 234:401-411.
49. Koivula T, Sibakov M, Palva I: Isolation and characterization of
Lactococcus lactis subsp. lactis promoters.  Appl Environ
Microbiol 1991, 57:333-340.
50. Geoffroy MC, Guyard C, Quatannens B, Pavan S, Lange M, Mercenier
A: Use of green fluorescent protein to tag lactic acid bacte-
rium strains under development as live vaccine vectors. Appl
Environ Microbiol 2000, 66:383-391.
51. Corthier G, Delorme C, Ehrlich SD, Renault P: Use of luciferase
genes as biosensors to study bacterial physiology in the
digestive tract. Appl Environ Microbiol 1998, 64:2721-2722.
52. Waterfield NR, Le Page RW, Wilson PW, Wells JM: The isolation
of lactococcal promoters and their use in investigating bac-
terial luciferase synthesis in Lactococcus lactis. Gene 1995,
165:9-15.
53. Thompson A, Gasson MJ: Location effects of a reporter gene on
expression levels and on native protein synthesis in Lacto-
coccus lactis and Saccharomyces cerevisiae.  Appl Environ
Microbiol 2001, 67:3434-3439.
54. Lee MH, Roussel Y, Wilks M, Tabaqchali S: Expression of Helico-
bacter pylori urease subunit B gene in Lactococcus lactis
MG1363 and its use as a vaccine delivery system against H.
pylori infection in mice. Vaccine 2001, 19:3927-3935.
55. Wells JM, Wilson PW, Norton PM, Gasson MJ, Le Page RW: Lacto-
coccus lactis: high-level expression of tetanus toxin fragment
C and protection against lethal challenge. Mol Microbiol 1993,
8:1155-1162.
56. Theisen M, Soe S, Brunstedt K, Follmann F, Bredmose L, Israelsen H,
Madsen SM, Druilhe P: A Plasmodium falciparum GLURP-
MSP3 chimeric protein; expression in Lactococcus lactis,
immunogenicity and induction of biologically active
antibodies. Vaccine 2004, 22:1188-1198.
57. Cortes-Perez NG, Bermudez-Humaran LG, Le Loir Y, Rodriguez-
Padilla C, Gruss A, Saucedo-Cardenas O, Langella P, Montes-de-Oca-
Luna R: Mice immunization with live lactococci displaying a
surface anchored HPV-16 E7 oncoprotein. FEMS Microbiol Lett
2003, 229:37-42.
58. Langella P, Le Loir Y: Heterologous protein secretion in Lacto-
coccus lactis: a novel antigen delivery system. Braz J Med Biol
Res 1999, 32:191-198.
59. Gil MT, Perez-Arellano I, Buesa J, Perez-Martinez G: Secretion of
the rotavirus VP8* protein in Lactococcus lactis. FEMS Micro-
biol Lett 2001, 203:269-274.
60. Steidler L, Wells JM, Raeymaekers A, Vandekerckhove J, Fiers W,
Remaut E: Secretion of biologically active murine interleukin-
2 by Lactococcus lactis subsp. lactis. Appl Environ Microbiol 1995,
61:1627-1629.
61. Steidler L, Robinson K, Chamberlain L, Schofield KM, Remaut E, Le
Page RW, Wells JM: Mucosal delivery of murine interleukin-2
(IL-2) and IL-6 by recombinant strains of Lactococcus lactis
coexpressing antigen and cytokine.  Infect Immun 1998,
66:3183-3189.
62. Sinha B, Francois P, Que YA, Hussain M, Heilmann C, Moreillon P,
L e w  D ,  K r a u s e  K H ,  P e t e r s  G ,  H e r r m a n n  M :  Heterologously
expressed Staphylococcus aureus fibronectin-binding pro-
teins are sufficient for invasion of host cells. Infect Immun 2000,
68:6871-6878.
63. Que YA, Haefliger JA, Francioli P, Moreillon P: Expression of Sta-
phylococcus aureus clumping factor A in Lactococcus lactis
subsp. cremoris using a new shuttle vector. Infect Immun 2000,
68:3516-3522.
64. O'Brien LM, Walsh EJ, Massey RC, Peacock SJ, Foster TJ: Staphylo-
coccus aureus clumping factor B (ClfB) promotes adherence
to human type I cytokeratin 10: implications for nasal
colonization. Cell Microbiol 2002, 4:759-770.
65. Wells CL, Moore EA, Hoag JA, Hirt H, Dunny GM, Erlandsen SL:
Inducible expression of Enterococcus faecalis aggregation
substance surface protein facilitates bacterial internalization
by cultured enterocytes. Infect Immun 2000, 68:7190-7194.
66. Gilbert C, Robinson K, Le Page RW, Wells JM: Heterologous
expression of an immunogenic pneumococcal type 3 capsu-
lar polysaccharide in Lactococcus lactis.  Infect Immun 2000,
68:3251-3260.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Microbial Cell Factories 2005, 4:2 http://www.microbialcellfactories.com/content/4/1/2
Page 13 of 13
(page number not for citation purposes)
67. Flynn S, van Sinderen D, Thornton GM, Holo H, Nes IF, Collins JK:
Characterization of the genetic locus responsible for the
production of ABP-118, a novel bacteriocin produced by the
probiotic bacterium Lactobacillus salivarius subsp. salivarius
UCC118. Microbiology 2002, 148:973-984.
68. Martinez JM, Kok J, Sanders JW, Hernandez PE: Heterologous
coproduction of enterocin A and pediocin PA-1 by Lactococ-
cus lactis: detection by specific peptide-directed antibodies.
Appl Environ Microbiol 2000, 66:3543-3549.
69. van Belkum MJ, Worobo RW, Stiles ME: Double-glycine-type
leader peptides direct secretion of bacteriocins by ABC
transporters: colicin V secretion in Lactococcus lactis. Mol
Microbiol 1997, 23:1293-1301.
70. Giuliano M, Schiraldi C, Marotta MR, Hugenholtz J, De Rosa M:
Expression of Sulfolobus solfataricus alpha-glucosidase in
Lactococcus lactis. Appl Microbiol Biotechnol 2004, 64:829-832.
71. Gaeng S, Scherer S, Neve H, Loessner MJ: Gene cloning and
expression and secretion of Listeria monocytogenes bacteri-
ophage-lytic enzymes in Lactococcus lactis.  Appl Environ
Microbiol 2000, 66:2951-2958.
72. van de Guchte M, van der Vossen JM, Kok J, Venema G: Construc-
tion of a lactococcal expression vector: expression of hen egg
white lysozyme in Lactococcus lactis subsp. lactis. Appl Environ
Microbiol 1989, 55:224-228.
73. van de Guchte M, Kodde J, van der Vossen JM, Kok J, Venema G: Het-
erologous gene expression in Lactococcus lactis subsp. lactis:
synthesis, secretion, and processing of the Bacillus subtilis
neutral protease. Appl Environ Microbiol 1990, 56:2606-2611.
74. Kahala M, Palva A: The expression signals of the Lactobacillus
brevis slpA gene direct efficient heterologous protein pro-
duction in lactic acid bacteria.  Appl Microbiol Biotechnol 1999,
51:71-78.
75. Wolinowska R, Ceglowski P, Kok J, Venema G: Isolation, sequence
and expression in Escherichia coli, Bacillus subtilis and Lac-
tococcus lactis of the DNase (streptodornase)-encoding
gene from Streptococcus equisimilis H46A.  Gene 1991,
106:115-119.
76. Simons G, Rutten G, Hornes M, Nijhuis M, van Asseldonk M: Pro-
duction of prochymosin in lactococci. Adv Exp Med Biol 1991,
306:115-119.
77. Drouault S, Corthier G, Ehrlich SD, Renault P: Expression of the
Staphylococcus hyicus lipase in Lactococcus lactis. Appl Envi-
ron Microbiol 2000, 66:588-598.
78. Arnau J, Hjerl-Hansen E, Israelsen H: Heterologous gene expres-
sion of bovine plasmin in Lactococcus lactis.  Appl Microbiol
Biotechnol 1997, 48:331-338.
79. Callegari ML, Riboli B, Sanders JW, Cocconcelli PS, Kok J, Venema G,
Morelli L: The S-layer gene of Lactobacillus helveticus CNRZ
892: cloning, sequence and heterologous expression. Microbi-
ology 1998, 144 (Pt 3):719-726.